Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FARYDAK
- Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
- Phase I Study of Marizomib + Panobinostat for Children With DIPG
- Panobinostat Maintenance After HSCT fo High-risk AML and MDS
- Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
- A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
- Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
- Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
- Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
- CINC424A2X01B Rollover Protocol
- Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
- LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
Clinical trials list
click for details